Scholz H, Kurtz A
Institut für Physiologie, Universität Regensburg, Germany.
J Clin Invest. 1993 Mar;91(3):1088-94. doi: 10.1172/JCI116266.
Using isolated rat kidneys perfused at controlled pressure, we examined a potential role of endothelium-derived relaxing factor (EDRF) in the pressure control of renin secretion. We found that stimulation of EDRF release by acetylcholine (1 mumol/liter) increased mean perfusate flow rates from 15.0 +/- 0.5 to 18.0 +/- 0.5 ml/min per g and average renin secretion rates from 3.5 +/- 0.5 to 16.0 +/- 2.0 ng angiotensin I/h per min per g at a perfusion pressure of 100 mmHg (mean +/- SEM, n = 6). Those effects of acetylcholine were significantly reduced during inhibition of EDRF formation with NG-nitro-L-arginine (100 mumol/liter), but they were not affected with the cyclooxygenase inhibitor indomethacin (10 mumol/liter). Lowering of the perfusion pressure from 100 mmHg to 40 mmHg resulted in an increase of average renin secretion rates from 3.5 +/- 0.5 to 79 +/- 12 ng AngI/h per min per g under control conditions (n = 8), and to 171 +/- 20 ng AngI/h per min per g in the presence of 10 mumol/liter acetylcholine (n = 3). The rise of renin secretion in response to a reduction of the renal artery pressure was markedly attenuated with inhibitors of EDRF formation such as NG-nitro-L-arginine (100 mumol/liter) and related compounds. During inhibition of EDRF formation, addition of sodium nitroprusside (10 mumol/liter) increased mean perfusate flow rates from 12.0 +/- 0.5 to 23.0 +/- 2.0 ml/min per g and average renin secretion rates from 2.0 +/- 0.5 to 18.0 +/- 1.5 ng AngI/h per min per g at 100 mmHg (n = 5). Lowering of the perfusion pressure from 100 mmHg to 40 mmHg under those conditions increased average renin secretion rates to 220 +/- 14 ng AngI/h per min per g (n = 5). Taken together, our findings suggest that EDRF and related activators of soluble guanylate cyclase stimulate renin secretion from isolated kidneys, predominantly at lower perfusion pressure. Moreover, pressure control of renin secretion appears to require the tonical stimulation by intrarenal EDRF.
我们使用在可控压力下灌注的离体大鼠肾脏,研究了内皮源性舒张因子(EDRF)在肾素分泌压力控制中的潜在作用。我们发现,乙酰胆碱(1 μmol/升)刺激EDRF释放,使灌注液平均流速从15.0±0.5增加至18.0±0.5毫升/分钟/克,在100 mmHg灌注压力下(平均值±标准误,n = 6),平均肾素分泌率从3.5±0.5增加至16.0±2.0纳克血管紧张素I/小时/分钟/克。在用NG-硝基-L-精氨酸(100 μmol/升)抑制EDRF形成期间,乙酰胆碱的这些作用显著减弱,但不受环氧合酶抑制剂吲哚美辛(10 μmol/升)的影响。在对照条件下(n = 8),灌注压力从100 mmHg降至40 mmHg导致平均肾素分泌率从3.5±0.5增加至79±12纳克血管紧张素I/小时/分钟/克,在存在10 μmol/升乙酰胆碱时(n = 3)增加至171±20纳克血管紧张素I/小时/分钟/克。用EDRF形成抑制剂如NG-硝基-L-精氨酸(100 μmol/升)及相关化合物处理后,肾动脉压力降低引起的肾素分泌增加明显减弱。在抑制EDRF形成期间,加入硝普钠(10 μmol/升)使100 mmHg时灌注液平均流速从12.0±0.5增加至23.0±2.0毫升/分钟/克,平均肾素分泌率从2.0±0.5增加至18.0±1.5纳克血管紧张素I/小时/分钟/克(n = 5)。在这些条件下,灌注压力从100 mmHg降至40 mmHg使平均肾素分泌率增加至220±14纳克血管紧张素I/小时/分钟/克(n = 5)。综上所述,我们的研究结果表明,EDRF和可溶性鸟苷酸环化酶的相关激活剂主要在较低灌注压力下刺激离体肾脏分泌肾素。此外,肾素分泌的压力控制似乎需要肾内EDRF的持续性刺激。